AAAAAA
Results: 1-25/28
Authors:
KAUFMANN SH
GORE SD
MILLER CB
JONES RJ
ZWELLING LA
SCHNEIDER E
BURKE PJ
KARP JE
Citation: Sh. Kaufmann et al., TOPOISOMERASE-II AND THE RESPONSE TO ANTILEUKEMIC THERAPY, Leukemia & lymphoma, 29(3-4), 1998, pp. 217-237
Authors:
KAUFMANN SH
KARP JE
SVINGEN PA
KRAJEWSKI S
BURKE PJ
GORE SD
REED JC
Citation: Sh. Kaufmann et al., ELEVATED EXPRESSION OF THE APOPTOTIC REGULATOR MCL-1 AT THE TIME OF LEUKEMIC RELAPSE, Blood, 91(3), 1998, pp. 991-1000
Authors:
KAUFMANN SH
KARP JE
BURKE PJ
GORE SD
Citation: Sh. Kaufmann et al., ADDITION OF ETOPOSIDE TO INITIAL THERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A COMBINED CLINICAL AND LABORATORY STUDY (VOL 23, PG 71, PG 1996), Leukemia & lymphoma, 24(5-6), 1997, pp. 3-3
Authors:
KARP JE
Citation: Je. Karp, ACUTE-LEUKEMIA - MECHANISMS OF CELL-SURVIVAL AS TARGETS FOR THERAPY (REVIEW), International journal of oncology, 11(4), 1997, pp. 657-674
Authors:
KELLOFF GJ
HAWK ET
KARP JE
CROWELL JA
BOONE CW
STEELE VE
LUBET RA
SIGMAN CC
Citation: Gj. Kelloff et al., PROGRESS IN CLINICAL CHEMOPREVENTION, Seminars in oncology, 24(2), 1997, pp. 241-252
Authors:
KARP JE
SMITH MA
Citation: Je. Karp et Ma. Smith, THE MOLECULAR PATHOGENESIS OF TREATMENT-INDUCED (SECONDARY) LEUKEMIAS- FOUNDATIONS FOR TREATMENT AND PREVENTION, Seminars in oncology, 24(1), 1997, pp. 103-113
Authors:
BERG PE
HUGUENIN S
RUSCETTI FW
KARP JE
ROSS DD
HAGA S
Citation: Pe. Berg et al., BP1, A NEW HOMEOBOX GENE, IS ABERRANTLY EXPRESSED IN ACUTE LEUKEMIAS, Blood, 90(10), 1997, pp. 3670-3670
Authors:
SOTOMAYOR EM
PIANTADOSI S
MILLER CB
KARP JE
KAUFMANN SH
BRAINE H
HUMPHREY RL
BURKE PJ
GORE SD
Citation: Em. Sotomayor et al., LONG-TERM FOLLOW-UP OF INTENSIVE, ARA-C-BASED CHEMOTHERAPY FOLLOWED BY BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - IMPROVED SURVIVAL WITH ALLOGENEIC, BUT NOT AUTOLOGOUS BMT, Blood, 90(10), 1997, pp. 1484-1484
Authors:
SMITH MA
MCCAFFREY RP
KARP JE
Citation: Ma. Smith et al., THE SECONDARY LEUKEMIAS - CHALLENGES AND RESEARCH DIRECTIONS, Journal of the National Cancer Institute, 88(7), 1996, pp. 407-418
Authors:
KARP JE
SMITH MA
Citation: Je. Karp et Ma. Smith, MODIFYING RISKS OF SECONDARY LEUKEMIAS - IS DRUG SCHEDULING IMPORTANT, Journal of the National Cancer Institute, 88(24), 1996, pp. 1787-1789
Authors:
KAUFMANN SH
KARP JE
BURKE PJ
GORE SD
Citation: Sh. Kaufmann et al., ADDITION OF ETOPOSIDE TO INITIAL THERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A COMBINED CLINICAL AND LABORATORY STUDY, Leukemia & lymphoma, 23(1-2), 1996, pp. 71-83
Authors:
KARP JE
PLUDA JM
YARCHOAN R
Citation: Je. Karp et al., AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES, Hematology/oncology clinics of North America, 10(5), 1996, pp. 1031
Authors:
KARP JE
CHIARODO A
BRAWLEY O
KELLOFF GJ
Citation: Je. Karp et al., PROSTATE-CANCER PREVENTION - INVESTIGATIONAL APPROACHES AND OPPORTUNITIES, Cancer research, 56(24), 1996, pp. 5547-5556
Authors:
KARP JE
BRODER S
Citation: Je. Karp et S. Broder, MOLECULAR FOUNDATIONS OF CANCER - NEW TARGETS FOR INTERVENTION, Nature medicine, 1(4), 1995, pp. 309-320
Authors:
BRODER S
KARP JE
Citation: S. Broder et Je. Karp, PROGRESS AGAINST CANCER, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 633-647
Authors:
KAUFMANN SH
CHARRON M
BURKE PJ
KARP JE
Citation: Sh. Kaufmann et al., CHANGES IN TOPOISOMERASE-I LEVELS AND LOCALIZATION DURING MYELOID MATURATION IN-VITRO AND IN-VIVO, Cancer research, 55(6), 1995, pp. 1255-1260
Authors:
SCHNEIDER E
COWAN KH
BADER H
TOOMEY S
SCHWARTZ GN
KARP JE
BURKE PJ
KAUFMANN SH
Citation: E. Schneider et al., INCREASED EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN RELAPSED ACUTE-LEUKEMIA, Blood, 85(1), 1995, pp. 186-193
Authors:
KARP JE
MCCAFFREY RP
Citation: Je. Karp et Rp. Mccaffrey, NEW AVENUES OF TRANSLATIONAL RESEARCH IN LEUKEMIA AND LYMPHOMA - OUTGROWTH OF A LEUKEMIA-SOCIETY-OF-AMERICA NATIONAL-CANCER-INSTITUTE WORKSHOP, Journal of the National Cancer Institute, 86(16), 1994, pp. 1196-1201
Authors:
KARP JE
MERZ WG
DICK JD
Citation: Je. Karp et al., MANAGEMENT OF INFECTIONS IN NEUTROPENIC PATIENTS - NEW OPPORTUNITIES AND EMERGING CHALLENGES, Current opinion in infectious diseases, 7(4), 1994, pp. 430-435
Authors:
KARP JE
BRODER S
Citation: Je. Karp et S. Broder, ONCOLOGY AND HEMATOLOGY, JAMA, the journal of the American Medical Association, 271(21), 1994, pp. 1693-1695
Authors:
KARP JE
BRODER S
Citation: Je. Karp et S. Broder, NEW DIRECTIONS IN MOLECULAR MEDICINE, Cancer research, 54(3), 1994, pp. 653-665
Authors:
GELLER RB
KARP JE
Citation: Rb. Geller et Je. Karp, ADULT ACUTE-LEUKEMIA - A NEED FOR CONTINUED TRANSLATIONAL RESEARCH, Blood, 84(11), 1994, pp. 3980-3981
Authors:
KAUFMANN SH
KARP JE
JONES RJ
MILLER CB
SCHNEIDER E
ZWELLING LA
COWAN K
WENDEL K
BURKE PJ
Citation: Sh. Kaufmann et al., TOPOISOMERASE-II LEVELS AND DRUG-SENSITIVITY IN ADULT ACUTE MYELOGENOUS LEUKEMIA, Blood, 83(2), 1994, pp. 517-530
Authors:
KARP JE
Citation: Je. Karp, STAT BITE - AIDS-RELATED CANCERS IN YOUNG WHITE MEN, Journal of the National Cancer Institute, 85(14), 1993, pp. 1114-1114
Authors:
KARP JE
MERZ WG
DICK JD
Citation: Je. Karp et al., MANAGEMENT OF INFECTIONS IN NEUTROPENIC PATIENTS - ADVANCES IN THERAPY AND PREVENTION, Current opinion in infectious diseases, 6(3), 1993, pp. 405-411